Dopaminergic modulation of low-Mg2+-induced epileptiform activity in the intact hippocampus of the newborn mouse in vitro

To investigate whether epileptiform activity in the immature brain is modulated by dopamine, we examined the effects of dopaminergic agonists and antagonists in an intact in vitro preparation of the isolated corticohippocampal formation of immature (postnatal days 3 and 4) C57/Bl6 mice using field p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroscience research 2012-10, Vol.90 (10), p.2020-2033
Main Authors: Sharopov, Salim, Moser, Jochen, Chen, Rongqing, Kolbaev, Sergey N., Bernedo, Viviane E., Werhahn, Konrad J., Luhmann, Heiko J., Kilb, Werner
Format: Article
Language:English
Subjects:
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology
Animals
Animals, Newborn
Benzazepines - pharmacology
Data Interpretation, Statistical
development
Dopamine - pharmacology
Dopamine - physiology
Dopamine Agonists - pharmacology
Dopamine Antagonists - pharmacology
Dopamine D2 Receptor Antagonists
dopamine receptor
epilepsy
Epilepsy - physiopathology
Hippocampus - physiopathology
Indoles - pharmacology
Magnesium Deficiency - physiopathology
Mice
Mice, Inbred C57BL
Nitriles - pharmacology
Piperidines - pharmacology
Quinpirole - pharmacology
Receptors, Dopamine D2 - agonists
seizures
Synapses - drug effects
Tetrahydroisoquinolines - pharmacology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To investigate whether epileptiform activity in the immature brain is modulated by dopamine, we examined the effects of dopaminergic agonists and antagonists in an intact in vitro preparation of the isolated corticohippocampal formation of immature (postnatal days 3 and 4) C57/Bl6 mice using field potential recordings from CA3. Epileptiform discharges were induced by a reduction of the extracellular Mg2+ concentration to 0.2 mM. These experiments revealed that low concentrations of dopamine (3 μM dopamine enhanced epileptiform activity. The D1‐agonist SKF38393 (10 μM) had a strong proconvulsive effect, and the D2‐like agonist quinpirole (10 μM) mediated a weak anticonvulsive effect. The proconvulsive effect of 10 μM dopamine was completely abolished by the D1‐like receptor antagonist SCH39166 (2 μM) or the D2‐like antagonist sulpiride (10 μM), whereas the D2 antagonist L‐741626 (50 nM) and the D3 antagonist SB‐277011‐A (0.1 μM) were without effect. The anticonvulsive effect of 0.1 μM dopamine could be suppressed by D1‐like, D2, or D3 receptor antagonists. A proconvulsive effect of 10 μM dopamine was also observed when AMPA, NMDA, or GABAA receptors were blocked. In summary, these results suggest that 1) dopamine influences epileptiform activity already at early developmental stages; 2) dopamine can bidirectionally influence the excitability; 3) D1‐like receptors mediate the proconvulsive effect of high dopamine concentrations, although the pharmacology of the anticonvulsive effect is less clear; and 4) dopamine‐induced alterations in GABAergic and glutamatergic systems may contribute to this effect. © 2012 Wiley Periodicals, Inc.
ISSN:0360-4012
1097-4547
DOI:10.1002/jnr.23084